sch 42495 has been researched along with cgs 26129 in 3 studies
| Studies (sch 42495) | Trials (sch 42495) | Recent Studies (post-2010) (sch 42495) | Studies (cgs 26129) | Trials (cgs 26129) | Recent Studies (post-2010) (cgs 26129) |
|---|---|---|---|---|---|
| 18 | 5 | 0 | 9 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alton, KB; Alvarez, N; Hernandez, A; Patrick, JE | 1 |
| Banfield, CR; Batra, V; Fettner, SH; Kosoglou, T; Pai, S; Zhu, GR | 1 |
1 trial(s) available for sch 42495 and cgs 26129
| Article | Year |
|---|---|
Pharmacokinetic-pharmacodynamic (PK-PD) modeling for a new antihypertensive agent (neutral metalloendopeptidase inhibitor SCH 42354) in patients with mild to moderate hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Humans; Hypertension; Male; Methionine; Middle Aged; Placebos; Prodrugs; Protease Inhibitors | 1995 |
2 other study(ies) available for sch 42495 and cgs 26129
| Article | Year |
|---|---|
High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric de
Topics: Chromatography, High Pressure Liquid; Gold; Humans; Hypertension; Mercury; Methionine; Neprilysin; Sulfhydryl Compounds | 1992 |
SCH 42495.
Topics: Drugs, Investigational; Endopeptidases; Heart Failure; Humans; Hypertension; Methionine; Prodrugs; Protease Inhibitors | 1999 |